American Kratom Association (AKA) Urges Louisiana Governor to Veto SB 154 – A Dangerous and Unjust Criminalization Bill
Governor should protect Louisiana citizens and support science and common sense
American Kratom Association (AKA) is calling on Governor Jeff Landry to immediately veto SB 154, a bill that will unjustly criminalize more than 325,000 law-abiding Louisianans who currently use kratom as part of their personal health and wellness routines. If signed into law, SB 154 would strip these individuals—including many veterans—of safe access to kratom and turn them into criminals overnight.
SB 154 is based on misinformation and political favoritism, not science. During debate, proponents of the bill relied on incomplete and demonstrably false claims—ignoring the expert evaluations that led the U.S. Drug Enforcement Administration to decline scheduling kratom. Instead of protecting public health, this legislation caters to Senator Morris's campaign donors, including anti-kratom drug rehab centers and pharmaceutical interests that stand to profit from a ban.
'This bill isn't about public safety—it's about politics,' said Mac Haddow, Senior Fellow on Public Policy for the AKA. 'We're urging Governor Landry to reject this reckless criminalization effort and stand with the 325,000 Louisianans who responsibly use kratom, many of whom are veterans managing chronic pain and PTSD without dangerous opioids.'
The AKA strongly urges Governor Landry to veto SB 154 and instead convene a Louisiana Kratom Commission to:
Take Action Now
Louisiana residents can contact Governor Landry and ask him to veto SB 154 by visiting: www.protectkratom.org/louisiana
America should stand for facts—not fear, and for science—not special interests. Louisiana deserves thoughtful regulation—not blanket criminalization.
About American Kratom Association (AKA)
American Kratom Association (AKA) is a consumer-based, nonprofit organization, focused on furthering the latest science as guidance for kratom public policy. AKA works to give a voice to millions of Americans by fighting to protect their rights to access safe and natural kratom. For more information, visit americankratom.org and learn more at kratomanswers.org.
Media Contact
Mac Haddow
[email protected]
###
SOURCE: American Kratom Association (AKA)
Copyright 2025 EZ Newswire
https://app.eznewswire.com/news/american-kratom-association-aka-urges-louisiana-governor-to-veto-sb-154-a-dangerous-and-unjust-criminalization-bill
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
18 minutes ago
- Yahoo
Joe Biden 'optimistic' about treatment plan for Stage 4 prostate cancer
Former President Joe Biden said on May 30 that he is 'optimistic' about the treatment plan for his Stage 4 prostate cancer, which involves taking a daily pill for six weeks. "We're underway and all the folks are very optimistic," Biden said. 'The expectation is we're going to be able to beat this. It's not in any (other) organ. My bones are strong, it hasn't penetrated. So I'm feeling good.' More: Biden urges Americans to support veterans on anniversary of son Beau's death Doctors found a 'small nodule' on Biden's prostate during a routine exam; the 82-year-old was diagnosed Friday, May 16, according to a statement released by his office. Speaking to reporters at a Delaware Memorial Day event for the first time since announcing his diagnosis, Biden said that he is being treated by a top doctor in the field. Biden's physician has lived through the same aggressive form of cancer as the former president. 'We're all optimistic about the diagnosis. Matter of fact, one of the leading surgeons in the world is working with me and he was diagnosed with the same exact thing 32 years ago,' Biden said. 'He's alive and well, doing very well.' Biden spoke with reporters as he left the annual Memorial Day event at Veterans Memorial Park in New Castle, Delaware, which coincided with the 10th anniversary of his son Beau Biden's death. It was also the first time Biden spoke to reporters since a book was published raising questions about his physical and mental fitness while he was president. A White House spokeswoman alleged Thursday that former first lady Jill Biden conspired to keep her husband's health from the American people. When asked to respond, Biden, who had just given a 10-minute speech and walked over to the throng of reporters, joked, "You can see that I'm mentally incompetent and I can't walk." This article originally appeared on USA TODAY: Joe Biden 'optimistic' about cancer treatment, doctor, meds
Atlantic
25 minutes ago
- Atlantic
America's Newest Gamblers Are Playing a Dangerous Game
Gambling has swallowed American sports culture whole. Until early 2018, sports betting was illegal under federal law; today, it's legal in 39 states and Washington, D.C. (and easy enough to access through backdoor channels even in the states where it isn't). During NFL games, gambling commercials air more often than ads for beer. Commentators analyze not just whether a team can win, but if they might win by at least the number of points by which they're favored on betting apps. Nearly half of men younger than 50 now have an account with an online sports book, and Americans spent about $150 billion on sports wagers last year. I regularly get ads on my phone offering me a complimentary $200 in sports bets, as long as I gamble $5 first. As betting has overrun American sports, other forms of gambling are also on the rise. According to industry data, American casinos are more popular now than at any point on record. The age of their average patron had been crawling upward for years, but since sports betting was legalized at the federal level, it has plummeted by nearly a decade, to approximately 42. Some signs point to gambling problems increasing, too. No centralized entity tracks gambling addiction, but if its scale comes even close to matching the new scale of sports betting, the United States is unequipped to deal with it. In its power to ruin and even end lives, gambling addiction is remarkably similar to drug dependency. Imaging studies show that pathological gamblers and people with substance addictions share patterns of brain activity. They are more likely to experience liver disease, heart disease, and sleep deprivation, whether it originates in the anxiety of concealing a gambling addiction or because someone is up wagering on contests, such as cricket and table tennis, that happen in faraway time zones. The best national survey available, which dates to well before the rise of sports betting, found that 2 million to 4 million Americans will experience a gambling disorder at some point in their life; one in six people with a gambling disorder attempts suicide. Even if their death certificate says differently, 'I've had several patients who died because of the emotional pain from their gambling disorder,' Timothy Fong, a psychiatrist specializing in addiction treatment and a co-director of UCLA's gambling-studies program, told me. Fong, like the other researchers I spoke with, said that rapid forms of gambling, especially those that allow you to place multiple bets at one time, tend to be especially addictive. For decades, sports betting mostly involved wagers on who'd win a match, by how much, and total points scored—outcomes resolved over the course of hours. Now apps offer endless in-game bets decided in seconds. Last year, I watched the Super Bowl with a friend who bet on the national anthem lasting less than 90.5 seconds—the smart money, according to the analysts. He lost when Reba McEntire belted the song's last words twice. The ability to place one bet after another encourages a hallmark behavior of problem gamblers—when deep in the red, instead of walking away, they bet bigger. 'Viewing sports gambling as a way to make money is likely to end badly,' Joshua Grubbs, a gambling researcher at the University of New Mexico, told me. 'Gamblers that think that gambling is a way toward economic success or financial payouts almost always have far more problem-gambling symptoms.' And some apps actively blur the already hazy line between betting and other financial activities. For instance, the financial platform Robinhood, where millions of people trade meme stocks and manage their retirement accounts, began offering online sports 'events contracts' (a type of investment whose payout depends on traders' correctly predicting the outcome of a specified event) during March Madness this year through a partnership with the financial exchange Kalshi. (A Robinhood spokesperson told me this 'emergent asset class' differs significantly from sports betting because users, not the house, set the prices, and can more easily exit their positions. But the experience of 'investing' in an events contract is virtually indistinguishable from betting.) Financial markets have recently started offering services like this even in states where sports betting is illegal. State gambling regulators have called foul, but the federal government has so far made no move to stop the companies. As the courts sort out whether any of this is legal, Robinhood decided to let customers trade on the Indy 500 and the French Open. Several recent trends suggest that problem gambling might be on the rise in the U.S. Calls to state gambling helplines have increased. (This might be partly explained by advocacy groups marketing their helplines more aggressively than ever; gambling companies also tack the numbers onto their ubiquitous ads.) Fong said that he was recently invited to speak to a consortium of family lawyers, whose divorce clients have started asking, 'How do I protect my children from the damage of their father's gambling?' Researchers and counselors are especially worried about single young men who play in fantasy sports leagues, bet on sports, day trade, and consider gambling a good way to make money. Gamblers Anonymous is rolling out groups for young people. 'I'm treating guys who would never be caught dead in a casino,' James Whelan, a clinical psychologist who runs treatment clinics for gambling addiction in Tennessee, told me. These imperfect proxy measures, along with incomplete data trickling out of a few states, are the best indicators that researchers have about the extent of gambling addiction. Experts are also unsure how long any increase in problem gambling might last: Some studies suggest that the prevalence of gambling problems tends to equalize after a spike, but those findings are usually limited to physical casinos and remain debated within the field. According to researchers I spoke with, no study has established the prevalence of gambling addiction in the U.S. since sports betting became widespread. Federal agencies dedicated to alcoholism and substance abuse allocate billions of research dollars to American universities every year. Yet for decades, the federal government—the largest funder of American research—has earmarked zero dollars for research on gambling activity or addiction specifically, despite collecting millions annually from gambling taxes. (The Substance Abuse and Mental Health Services Administration, which collects national data on behavioral health and funds research into it, declined to comment.) Gambling-addiction treatment is '50 years behind where we are with drugs or alcohol or any other substance,' Michael Sciandra, the executive director of the Nebraska Council on Problem Gambling, told me. Doctors and therapists, even those who specialize in treating addiction, rarely screen for issues with gambling, he said. Among the handful of dedicated gambling-addiction treatment providers around the country, many deploy cognitive behavioral therapy, which studies suggest can at least temporarily improve patients' quality of life and reduce the severity of their gambling problem. But discrepancies in treatment approaches and tiny trial sizes make it difficult to say exactly how many patients the therapy helps. Two medications used to treat alcoholism and opioid addiction have also been found to reduce the severity of gambling addiction across a handful of small clinical trials. But the evidence needed for FDA approval would require large and expensive clinical trials that no one seems eager to fund, Marc Potenza, the director of Yale's Center of Excellence in Gambling Research, told me. Because the federal government doesn't fund gambling-addiction treatment, each state decides what resources to make available. A Tennessee caller to the national helpline 1-800-GAMBLER might be put through to their state's helpline and then connected to the network of government-subsidized clinics Whelan runs across the state. But in states with bare-bones offerings, workers typically refer callers to peer-support groups such as Gamblers Anonymous, or to online resources on budgeting, says Cole Wogoman, a director at the National Council on Problem Gambling, which runs the helpline. Studies have found that each of these strategies is less effective than therapy. Charles Fain Lehman: Legalizing sports gambling was a huge mistake Texas could be an example of how unprepared the U.S. is to deal with any increase in problem gamblers. The state's gambling laws are among the strictest in the country, and yet it still sends the second-highest number of callers (behind California) to 1-800-GAMBLER. This November, Texans might vote on a constitutional amendment to allow sports betting. The state of more than 30 million has no funding for gambling treatment and only three certified gambling counselors, according to Carol Ann Maner, who is one of them. The state's official hub for gambling help, which Maner leads, was founded just this spring. Once they find the money, Maner and her colleagues plan to finally set up the state's own helpline. But first, they need to recruit and train more therapists for a job that, thanks to a lack of state and federal funding, might require turning away uninsured clients. That's a daunting task. Finding the apps Texans can use to get around gambling restrictions is easy.
Yahoo
29 minutes ago
- Yahoo
California petitions FDA to undo RFK Jr.'s new limits on abortion pill mifepristone
California and three other states petitioned the U.S. Food and Drug Administration Thursday to ease its new restrictions on the abortion pill mifepristone, citing the drug's proven safety record and arguing the new limits are unnecessary. "The medication is a lifeline for millions of women who need access to time-sensitive, critical healthcare — especially low-income women and those who live in rural and underserved areas," said California Atty. Gen. Rob Bonta, who filed the petition alongside the attorneys general of Massachusetts, New York and New Jersey. The petition cites Senate testimony by Health and Human Services Secretary Robert F. Kennedy Jr. last month, in which Kennedy said he had ordered FDA administrator Martin Makary to conduct a "complete review" of mifepristone and its labeling requirements. The drug, which can be received by mail, has been on the U.S. market for 25 years and taken safely by millions of Americans, according to experts. It is the most common method of terminating a pregnancy in the U.S., with its use surging after the Supreme Court overturned Roe vs. Wade in 2022. The Supreme Court upheld access to the drug for early pregnancies under previous FDA regulations last year, but it has remained a target of anti-abortion conservatives. The Trump administration has given Kennedy broad rein to shake up American medicine under his "Make America Healthy Again" banner, and Kennedy has swiftly rankled medical experts by using dubious science — and even fake citations — to question vaccine regimens and research and other longstanding public health measures. Read more: Hiltzik: MAHA report's misrepresentations will harm public health and hit consumers' pocketbooks At the Senate hearing, Kennedy cited "new data" from a flawed report pushed by anti-abortion groups — and not published in any peer-reviewed journal — to question the safety of mifepristone, calling the report "alarming." "Clearly, it indicates that, at very least, the label should be changed," Kennedy said. Sen. Josh Hawley (R-Mo.) on Monday posted a letter from Makary to X, in which Makary wrote that he was "committed to conducting a review of mifepristone" alongside "the professional career scientists" at the FDA. Makary said he could not provide additional information given ongoing litigation around the drug. The states, in their 54-page petition, wrote that "no new scientific data has emerged since the FDA's last regulatory actions that would alter the conclusion that mifepristone remains exceptionally safe and effective," and that studies "that have frequently been cited to undermine mifepristone's extensive safety record have been widely criticized, retracted, or both." Democrats have derided Kennedy's efforts to reclassify mifepristone as politically motivated and baseless. "This is yet another attack on women's reproductive freedom and scientifically-reviewed health care," Gov. Gavin Newsom said the day after Kennedy's Senate testimony. "California will continue to protect every person's right to make their own medical decisions and help ensure that Mifepristone is available to those who need it." Bonta said Thursday that mifepristone's placement under the FDA's Risk Evaluation and Mitigation Strategy program for drugs with known, serious side effects — or REMS — was "medically unjustified," unduly burdened patient access and placed "undue strain on the nation's entire health system." He said mifepristone "allows people to get reproductive care as early as possible when it is safest, least expensive, and least invasive," is "so safe that it presents lower risks of serious complications than taking Tylenol," and that its long safety record "is backed by science and cannot be erased at the whim of the Trump Administration." Read more: Q&A: The FDA says the abortion pill mifepristone is safe. Here's the evidence The FDA has previously said that fewer than 0.5% of women who take the drug experience 'serious adverse reactions,' and deaths are exceedingly rare. The REMS program requires prescribers to add their names to national and local abortion provider lists, which can be a deterrent for doctors given safety threats, and pharmacies to comply with complex tracking, shipping and reporting requirements, which can be a deterrent to carrying the drug, Bonta said. It also requires patients to sign forms in which they attest to wanting to "end [their] pregnancy," which Bonta said can be a deterrent for women using the drug after a miscarriage — one of its common uses — or for those in states pursuing criminal penalties for women seeking certain abortion care. Under federal law, REMS requirements must address a specific risk posed by a drug and cannot be "unduly burdensome" on patients, and the new application to mifepristone "fails to meet that standard," Bonta said. The states' petition is not a lawsuit, but a regulatory request for the FDA to reverse course, the states said. If the FDA will not do so nationwide, the four petitioning states asked that it "exercise its discretion to not enforce the requirements" in their states, which Bonta's office said already have "robust state laws that ensure safe prescribing, rigorous informed consent, and professional accountability." Get the L.A. Times Politics newsletter. Deeply reported insights into legislation, politics and policy from Sacramento, Washington and beyond, in your inbox twice per week. This story originally appeared in Los Angeles Times.
